BioHarvest Sciences Inc. (BHST) stock
BHSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.22−0.16 (-11.59%)
Close on Nov 17, 2026Market cap $27.65MP/E –Yield –
BioHarvest Sciences cash
Cash and short-term investments held at the end of each period.
BioHarvest Sciences's cash was $23.03M at Dec 31, 2025. For fiscal 2025 it was $23.03M, up 863.4% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.03M | +863.4% |
| FY2024 | Dec 31, 2024 | $2.39M | -55.4% |
| FY2023 | Dec 31, 2023 | $5.36M | +208.5% |
| FY2022 | Dec 31, 2022 | $1.74M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | $23.03M | – |
| Q4 FY2024 | Dec 31, 2024 | $2.39M | – |
| Q4 FY2023 | Dec 31, 2023 | $5.36M | – |
| Q4 FY2022 | Dec 31, 2022 | $1.74M | – |
See a number that looks wrong?